Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aion Therapeutic Inc C.AION

Alternate Symbol(s):  ANTCF

Aion Therapeutic Inc is in the business of research and development, treatment, data mining and state-of-the-art artificial intelligence techniques, focused on the development of combinatorial pharmaceuticals, nutraceuticals and cosmeceuticals utilizing compounds from cannabis, psychedelic mushrooms, fungi, natural psychedelic formulations, and other medicinal plants in a legal environment for this type of discovery.


CSE:AION - Post by User

Aion Therapeutic Inc > I am very optimistic about AION Therapeutic potentiality.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(256)
•••
Comment by guerreiroon Sep 04, 2020 1:07am
144 Views
Post# 31509002

RE:RE:RE:I am very optimistic about AION Therapeutic potentiality.

RE:RE:RE:I am very optimistic about AION Therapeutic potentiality.This stock is doing really well as plans are coming together. Some strong buying today of large blocks. Some thing big must be going behing the scenes. It is believed that a lot of the buying is coming out of USA, as Dr. Stephen Barnhill as  a strong US base. hoping to see it back to .25 to .30 cents soon.
Aion Therapeutic Files Five Patents with the United States Patent and Trademark Office

Executive Chairman and inventor of these patents, Dr. Stephen Barnhill. "Natural products derived from plants have played a leading role in cancer drug discovery, which is demonstrated by the large number of approved anti-cancer agents derived from these sources. Such drugs include effective chemotherapeutic agents such as doxorubicin, irinotecan, topotecan, paclitaxel, docetaxel, and vincristine. Fungi-derived natural products have also been an excellent source of pharmaceuticals as well, including cyclosporine and certain types of statins. We firmly believe that combining compounds from cannabis and mushrooms (medical and edible) will create an entirely new class of successful therapeutic treatments."

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities